Recognizing the urgent need for treatment options and guided by patient insights, Pfizer scientists have discovered a way to ...

Cachexia is a metabolic disorder that has been increasingly focused upon in studies and clinical trials over the last decade. Although the understanding of this condition has improved considerably, ...

In 2011, Laura Beaver did not let the growing tumor in her body dictate her life. She kept up her normal hourlong gym routine. She took weekend bike rides near her Washington state home. She did the ...

Sept. 14 (UPI) --A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drugmaker Pfizer announced Saturday. The experimental ...

Cachexia – the massive depletion of muscle mass and adipose tissue – is commonly seen in people with cancer and other major illnesses. Also called cancer cachexia or cancer anorexia cachexia, it is a ...

Prophylactic use of filgrastim at nadir: Impact of haematological parameters on recovery of grade IV neutropenia induced by standard dose chemotherapy No significant financial relationships to ...

A recent study found promise in a new drug that treats cachexia, a progressive wasting syndrome. The trial is currently in canine patients, with hopes to move to human patients in the future. A new ...

Eating disorders are often thought of as body image disorders with symptoms of food restriction and purging. In most cases, the goal of these behaviors is to prevent weight gain. Not all eating ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. BARCELONA, Spain — Patients with advanced cancers often develop a ...

(June 6, 2002) BETHESDA, Md. -- AIDS and HIV infection have long been known to cause weight loss, a condition called AIDS wasting. With the advent of new medications, catastrophic wasting is no longer ...